BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET
For 30 tablets
Pharmacies pay
$3.67 filed
30 × $0.12231 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$9.22 estimated
$3.67 + $0.55 (15%) + $5.00 fee per fill = $9.22
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “butalbital, acetaminophen and caffeine” and “butalbital, acetaminophen, and caffeine”, as its NDCs’ listings variously write the nonproprietary name, under the trade name “Butalbital, Acetaminophen, Caffeine”.
FDA gives its dosage form as tablet and its route as oral.
FDA lists 10 labelers (the companies named on the label) for its NDCs, among them Lannett Company, Inc., Actavis Pharma, Inc. and Major Pharmaceuticals.
FDA lists it under 3 Established Pharmacologic Classes: Barbiturate, Central Nervous System Stimulant and Methylxanthine.
The NADAC file of 2026-10-14 prices it under 20 NDCs (National Drug Codes); the FDA directory lists 17 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $3.67 for 30 tablets (30 × $0.12231 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 10 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Actavis Pharma, Inc. | 2 | $0.12231 per EA filed |
| Granules Pharmaceuticals Inc. | 2 | $0.12231 per EA filed |
| KVK-Tech, Inc. | 2 | $0.12231 per EA filed |
| Lannett Company, Inc. | 2 | $0.12231 per EA filed |
| Mikart, LLC | 2 | $0.12231 per EA filed |
| QUAGEN PHARMACEUTICALS LLC | 2 | $0.12231 per EA filed |
| Westminster Pharmaceuticals, LLC | 2 | $0.12231 per EA filed |
| AvPAK | 1 | $0.12231 per EA filed |
| Chartwell RX, LLC | 1 | $0.12231 per EA filed |
| Major Pharmaceuticals | 1 | $0.12231 per EA filed |
| Not listed as a package in the FDA directory | 3 | $0.12231 per EA filed |
All 20 NDCs, with labeler and price
- 00527-1695-01 · Lannett Company, Inc. · $0.12231 per EA · eff. 2026-09-23 filed
- 00527-1695-05 · Lannett Company, Inc. · $0.12231 per EA · eff. 2026-09-23 filed
- 00591-3369-01 · Actavis Pharma, Inc. · $0.12231 per EA · eff. 2026-09-23 filed
- 00591-3369-05 · Actavis Pharma, Inc. · $0.12231 per EA · eff. 2026-09-23 filed
- 00904-6938-06 · Major Pharmaceuticals · $0.12231 per EA · eff. 2026-09-23 filed
- 10702-0253-01 · KVK-Tech, Inc. · $0.12231 per EA · eff. 2026-09-23 filed
- 10702-0253-50 · KVK-Tech, Inc. · $0.12231 per EA · eff. 2026-09-23 filed
- 46672-0053-10 · Mikart, LLC · $0.12231 per EA · eff. 2026-09-23 filed
- 46672-0053-50 · Mikart, LLC · $0.12231 per EA · eff. 2026-09-23 filed
- 50268-0553-11 · not listed as a package in the FDA directory · $0.12231 per EA · eff. 2026-09-23 filed
- 50268-0553-13 · AvPAK · $0.12231 per EA · eff. 2026-09-23 filed
- 62135-0751-01 · Chartwell RX, LLC · $0.12231 per EA · eff. 2026-09-23 filed
- 64380-0157-01 · not listed as a package in the FDA directory · $0.12231 per EA · eff. 2026-09-23 filed
- 64380-0157-02 · not listed as a package in the FDA directory · $0.12231 per EA · eff. 2026-09-23 filed
- 69367-0203-01 · Westminster Pharmaceuticals, LLC · $0.12231 per EA · eff. 2026-09-23 filed
- 69367-0203-05 · Westminster Pharmaceuticals, LLC · $0.12231 per EA · eff. 2026-09-23 filed
- 70010-0149-01 · Granules Pharmaceuticals Inc. · $0.12231 per EA · eff. 2026-09-23 filed
- 70010-0149-05 · Granules Pharmaceuticals Inc. · $0.12231 per EA · eff. 2026-09-23 filed
- 70752-0142-10 · QUAGEN PHARMACEUTICALS LLC · $0.12231 per EA · eff. 2026-09-23 filed
- 70752-0142-14 · QUAGEN PHARMACEUTICALS LLC · $0.12231 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
3 other products in the NADAC file share an FDA nonproprietary name with BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE | $0.31632 per EA filed | We don’t know yet |
| BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE | $1.93118 per EA filed | We don’t know yet |
| BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET this page | $0.12231 per EA filed | We don’t know yet |
| FIORICET 50-300-40 MG CAPSULE | $8.82367 per EA filed | $7.02553 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 20 NDCs’ NADAC prices is $0.12231 per EA filed.
Of the 10 other products in FDA’s Barbiturate class priced per EA, 10 have a higher middle NADAC price and 0 a lower one. The one in the middle is BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE, at $0.94823 per EA filed (eff. 2026-09-23).
Of the 203 other products in FDA’s Central Nervous System Stimulant class priced per EA, 187 have a higher middle NADAC price and 16 a lower one. The one in the middle is FOCALIN XR 5 MG CAPSULE, at $4.70352 per EA filed (eff. 2026-09-23).
Of the 32 other products in FDA’s Methylxanthine class priced per EA, 16 have a higher middle NADAC price and 16 a lower one. The one in the middle is QC STAY AWAKE 200 MG TABLET, at $0.08299 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Related pages
Its pharmacologic classes
Related in the same class
- BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE
- ASCOMP WITH CODEINE CAPSULE
- BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP
- ALERT AID 200 MG TABLET
- ASPIRIN-ACETAMINOPHEN-CAFFEINE TABLET